Login or Register to make a submission.

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.

  • The text adheres to the stylistic and bibliographic requirements outlined in the Author Guidelines.
  • The text is double-spaced; uses a 12-point font; employs italics, rather than underlining (except with URL addresses); and all illustrations, figures, and tables are placed at the end. If tables are used, they should be double spaced on separate pages. They should be numbered and cited in the text of the article. If abbreviations are used in the text, authors are required to write full name+abbreviation in brackets [e.g. Multiple Myeloma (MM)] the first time they are used, then only abbreviations can be written (apart from titles; in this case authors have to write always the full name).
  • The submission file is in OpenOffice, Microsoft Word, RTF, or PDF document file format.
  • The submission has not been previously published, nor is it before another journal for consideration (or an explanation has been provided in Comments to the Editor). While the manuscript is undergoing the peer review phase, the authors will not submit the manuscript to another journal without notifying the editor.
  • We fight plagiarism: please understand that your article will be checked with available tools for discovering plagiarism.
  • Please read this advice and download associated files. The International Committee of Medical Journal Editors has recently published in all ICMJE journals an editorial introducing a new “Disclosure Form for Potential Conflict of Interest”, with the aim to establish uniform reporting system, which can go over the existing differences in current formats or editors’ requests. We at PAGEPress Publications welcome this initiative as a possible uniforming, standardizing way to have this important disclosure authorizing the publications of manuscripts. We are therefore asking you to duly fill in the “Uniform Format for Disclosure of Competing Interests in ICMJE Journals” and upload it on the Web site of the PAGEPress journal your work is involved with or email it back to us, in mind to allow PAGEPress to peer-reviewing your work. The document is in Adobe format, it includes instructions to help authors provide the requested information and the completion procedure is user-friendly. Kindly note that the format have to be completed and signed by each author of the work. We remain waiting for the completed form to proceed with publication. Please be informed that if this Disclosure Form is missing, we will not be able to publish your work.
  • Authors are kindly invited to suggest potential reviewers (name, affiliation and e-mail) for their manuscript.

To submit a new paper to our journal:

  1. Register on the Journal website; we encourage you to register also as a Reviewer at the same time;
  2. Download and follow the Guidelines for Authors;
  3. Read our Editorial Policies and our Competing Interest policies.
  4. Log in;
  5. Click on the "MAKE A SUBMISSION" button to start the online procedure.

To submit a revised version:

  1. Log in;
  2. Click on the title of your paper;
  3. Next to the heading "REVISIONS", upload your revised paper by using the "UPLOAD FILE" button;
  4. Inform the Editors that a revised version has been uploaded.

Guidelines for Authors

The Corresponding Author must submit the manuscript online-only through our Manuscript Submission System.

Manuscripts should be in either British or American English consistently throughout. Check for consistent spelling of names, terms, and abbreviations, including in tables and figure captions. Ensure that your work is written in correct English before submission.

As an option, PAGEPress offers its own professional copyediting service. Professional copyediting can help authors improve the presentation of their work and increase its chances of being taken on by a publisher. In case you feel that your manuscript needs a professional English language copyediting checking language grammar and style, you can find a reliable revision service at:

Each manuscript should be typewritten, double-spaced throughout; pages should be in A4 format (2.5 cm margin left & right) and numbered, lines should be left numbered in continuum (10-digit numeric system). Headings must be used to designate the major divisions of the paper.

Manuscript formatting

The first page must contain: i) title (lowercase), without acronyms; ii) first name and family name of each author, separated by commas; iii) affiliation(s) of each author (in English); iv) acknowledgments; 
v) full name and full postal address of the corresponding author. Phone, fax number and e-mail address for the correspondence should also be included; vi) three to five key words.

The second page should contain: i) authors’ contributions, e.g., information about the contributions of each person named as having participated in the study (http://www.icmje.org/#author); ii) disclosures about potential conflict of interests; iii) further information (e.g., funding, conference presentation ...).

The Abstract must be analytically informative and not subdivided in headings. The Text should normally be subdivided into: Introduction, Materials and Methods, Results, Discussion.

If tables are used, they should be double-spaced on separate pages. They should be numbered and cited in the text of the manuscript. If figures are used, they should be numbered and cited in the text of the manuscript and inserted in the manuscript for the peer-review process; in case of acceptance, authors are required to provide the figures as .tiff or .jpg files, with the following digital resolution:
i) color (saved as CMYK): minimum 300 dpi;
ii) black and white/grays: minimum 600 dpi;
iii) one column width (8.5 cm) or 2 column widths (17.5 cm).

A different caption for each figure must be provided at the end of the manuscript. Figures with different panels have to be grouped into a plate, and panels marked with letters.

If abbreviations are used in the text, authors are required to write full name+abbreviation in brackets [e.g. Multiple Myeloma (MM)] the first time they are used in the Abstract and in the first manuscript section, then only abbreviations can be written (apart from titles; in this case authors have to write always the full name).
If names of equipment or substances are mentioned in the text, brand, company names and locations (city and state) for equipment and substances should be included in parentheses within the text.

Numbers
For numbers less than one use zero to the left of the decimal, e.g. 0.23. Do not use commas for four digit numbers, e.g. 9000, and use commas for numbers with more than four digits, e.g. 90,000.

Original Articles (3500 words max, abstract 350 words max, 50 references max, 3/5 tables and/or figures): Reports of basic and applied research in the field of emergency care. In general, this kind of publication should be divided into an Abstract, Introduction, Materials and Methods, Results, Discussion, Conclusions and References. A maximum of 10 authors is permitted and additional authors should be listed in an ad hoc Appendix.

Reviews (5000 words max, abstract 250 words max, 40 to 100 references, 3/5 tables and/or figures): They should be introduced by a general summary of content in the form of an Abstract. Following a short introduction, putting the study into context and defining the aim, reviews will concentrate on the most recent clinical updates in the field and summarize the state-of-the-art literature. A review should clearly describe the search strategy followed (key words, inclusion, exclusion criteria, search engines, ...). No particular format is required; headings should be used to designate the major divisions of the paper.

Case Reports (about 2000 words, abstract 150 words max, 20 references max, 3 tables and/or figures): Reports describing observations on clinical cases that can be educational, including adverse effects of drugs or outcomes of a specific treatment. They should be divided into: Abstract, Introduction (optional), Case report(s), Discussion, Conclusions and References.

Letters to the Editor (1000 words max, no abstract needed, 3 references): Letters should address specific scientific issues raised by papers published by Monaldi Archives for Chest Disease or deliver information / news regarding an issue related to the Journal scope. Authors of papers cited in the Letters will be given the opportunity to respond. Letters that are highly polemic will not be published. Letters are not peer reviewed and are published at the discretion of the Monaldi Archives for Chest Disease editors. Conclusions and opinions expressed by the authors do not necessarily reflect the policies of Monaldi Archives for Chest Disease.

For further details on the specific layout to follow for the different types of papers published by the Journal, please refer to the Section Policies.

References

References should be prepared strictly according to the Vancouver style and must be numbered consecutively in the order in which they are first cited in the text (not alphabetical order); they must be identified in the text as number in square brackets. References to personal communications and unpublished data should be incorporated in the text and not placed under the numbered references [Example: (Wright 2011, unpublished data) or (Wright 2011, personal communication)]. Where available, URLs for the references should be provided directly within the MS-Word document. Authors are responsible for the accuracy of their references.

References in the References section must be prepared as follows:i) more than three authors, cite 3 authors, et al. If the paper has only 4 authors, cite all authors; 
ii) title style: sentence case; please use a capital letter only for the first word of the title; 
iii) journal titles mentioned in the References list should be abbreviated according to the following websites:
a. ISI Journal Abbreviations Index (http://library.caltech.edu/reference/abbreviations/);
b. Biological Journals and Abbreviations (http://home.ncifcrf.gov/research/bja/);
c. Medline List of Journal Titles (ftp://ftp.ncbi.nih.gov/pubmed/J_Medline.txt);
iv) put year after the journal name; 
v) never put month and day in the last part of the references; 
vi) cite only the volume (not the issue in brackets); 
vii) pages have to be abbreviated, e.g., 351-8. 

To ensure the correct citation format, please check your references in the PubMed database (http://www.ncbi.nlm.nih.gov/pubmed).

Examples:

Standard journal article

Halpern SD, Ubel PA, Caplan AL. Solid-organ transplantation in HIV-infected patients. N Engl J Med 2002;347:284-7.

Proceedings

Christensen S, Oppacher F. An analysis of Koza's computational effort statistic for genetic programming. In: Foster JA, Lutton E, Miller J, Ryan C, Tettamanzi AG, eds. Genetic programming. EuroGP 2002: Proceedings of the 5th European Conference on Genetic Programming, 2002 Apr 3-5, Kinsdale, Ireland. Berlin: Springer; 2002. pp 182-91.

Article with organization as author

Diabetes Prevention Program Research Group. Hypertension, insulin, and proinsulin in participants with impaired glucose tolerance. Hypertension 2002;40:679-86.

Books

Murray PR, Rosenthal KS, Kobayashi GS, Pfaller MA. Medical microbiology. 4th ed. St. Louis, MO: Mosby; 2002.

Bjørn Lomborg, ed. RethinkHIV - Smarter ways to invest in ending HIV in Sub-Saharan Africa. Cambridge: Cambridge University Press; 2012.

Meltzer PS, Kallioniemi A, Trent JM. Chromosome alterations in human solid tumors. In: Vogelstein B, Kinzler KW, eds. The genetic basis of human cancer. New York, NY: McGraw-Hill; 2002. pp 93-113.

Permissions

In case extracts (text/figures/tables) from other copyrighted works are included, the author(s) must obtain written permission from the copyright holder(s) and credit the source(s) in the article, for example: 'Adapted from Kovačević et al., Monaldi Arch Chest Dis 2013;79:61-66; with permission.' The editorial office of Monaldi Archives for Chest Disease needs to receive a copy of the written permission before proceeding with publication.

Peer-review policy

Our journal follow the COPE Code of Conduct and Best Practice Guidelines for Journal Editors.

The Editorial Board of each journal will immediately screen all articles submitted for publication in that journal. Those articles which fail to reach the scientific standards of the journal may be declined without further review. Those articles which satisfy the requirements of the Editorial Board will be sent to a maximum of three referees. These are experts in the field who have agreed to provide a rapid assessment of the article. Every effort will be made to provide an editorial decision as to acceptance for publication within 4-6 weeks of submission. Referees may request a revision of the article to be made. In this case, it is generally understood that only one revised version can be considered for a further appraisal under the peer-review system. The Editorial Board of our journal is responsible for the final selection of referees to conduct the peer-review process for that journal. The names of referees will not be made available to authors. However, referees will be informed as to the identity of the authors whose articles are subject to review. All members of the Editorial Board and referees are asked to declare any competing interests they may have in reviewing a manuscript. If on receiving the editorial decision concerning their manuscript authors are not satisfied they are invited to appeal to the Editorial Office. In cases in which this is considered appropriate a second opinion on the manuscript will be requested.

Publication Frequency

All papers are published as soon as they have been accepted, by adding them to the "current" volume's Table of Contents.

Open Access Policy

This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.

Pre- and post-prints

PAGEPress allows and encourages authors to deposit both their pre- and post-prints in Open-Access institutional archives or repositories. The primary benefit of pre- and post-print self-archiving is reaching a larger audience which enhances the visibility and impact of your research.

Indexing

PAGEPress is currently working with the major databases and online resources, such as Pubmed/Medline, Pubmedcentral, Google Scholar, Directory of Open Access Journals (DOAJ), IndexCopernicus, Chemical Abstracts Service, OpenJ-Gate, Ulrich's Periodicals Directory, Sherpa/Romeo, Socolar, to track Monaldi Archives for Chest Disease articles. PAGEPress also have agreements with EBSCO Host, Elsevier Scopus, Bibliosan to track this Journal. PAGEPress is also working closely with Clarivate Analytics (ISI) to ensure that citation analysis of articles published in this Journal will be available as soon as possible.

Archiving

This journal utilizes the PKP Preservation Network, the Global LOCKSS Network and Portico to create a distributed archiving system among participating libraries and permits those libraries to create permanent archives of the journal for purposes of preservation and restoration. 

Publication Ethics

Editorship
PAGEPress strongly support the mission of the COPE Code of Conduct and Best Practice Guidelines for Journal Editors; all individuals collaborating with PAGEPress are strongly invited to comply with this mission.

Ethics
All research articles published by PAGEPress journals are subject to a rigorous ethical standards. Our journals endorses the Code of Conduct of the Committee on Publication Ethics (COPE), as well as the COPE International Standards for Editors and Authors Guidelines. The Editorial Board of each journal is responsible for the form the peer review process will take; therefore, all authors in the biomedical field must adhere to the Uniform Requirements for Manuscripts Submitted to Biomedical Journals. PAGEPress endorses the World Association of Medical Editors (WAME) Policy Statement on Geopolitical Intrusion on Editorial Decisions, too.

Plagiarism

The Editorial Board of our journals will immediately screen all articles submitted for publication in that journal. All submissions we receive are checked for plagiarism by using plagiarism detection online available tools such as iThenticate®. Any suspected misconduct ends up with a quick rejection and is then reported to the European Network of Research Integrity Offices and to the US Office of Research Integrity. The European Federation of Academies of Sciences and Humanities (ALLEA) released a European Code of Conduct on Research Integrity, which is fully supported by our journals. The European Science Foundation released a Code of Conduct on Research Integrity, which is fully supported by our journals. All authors submitting papers to our journals are required to adopt these policies.

Below some online resource to help you in understanding plagiarism:

Roig, M. Avoiding plagiarism, self-plagiarism, and other questionable writing practices: A guide to ethical writing. St Johns University.

Long TC, Errami M, George AC, et al. Responding to Possible Plagiarism. Science 2009; 323:1293-1294.

Lewis J, Ossowski S, Hicks J, Errami M, and Garner HR. Text similarity: an alternative way to search MEDLINE. Bioinformatics 2006; 22:2298-2304.

Authorship
All persons designated as authors should qualify for authorship according to the ICMJE criteria (http://www.icmje.org/ethical_1author.html). Each author should have participated sufficiently in the work to take public responsibility for the content. Authorship credit should only be based on substantial contributions to i) conception and design, or analysis and interpretation of data; and to ii) drafting the article or revising it critically for important intellectual content; and on iii) final approval of the version to be published. These three conditions must all be met. Participation solely in the acquisition of funding or the collection of data does not justify authorship. General supervision of the research group is not sufficient for authorship. Any part of an article critical to its main conclusions must be the responsibility of at least one author. Authors should provide a brief description of their individual contributions.

Conflict of Interest

Conflict of interest exists when an author (or the author's institution), reviewer, or editor has financial or personal relationships that inappropriately influence (bias) his or her actions (such relationships are also known as dual commitments, competing interests, or competing loyalties). These relationships vary from negligible to great potential for influencing judgment. Not all relationships represent true conflict of interest. On the other hand, the potential for conflict of interest can exist regardless of whether an individual believes that the relationship affects his or her scientific judgment. Financial relationships (such as employment, consultancies, stock ownership, honoraria, and paid expert testimony) are the most easily identifiable conflicts of interest and the most likely to undermine the credibility of the journal, the authors, and of science itself. However, conflicts can occur for other reasons, such as personal relationships, academic competition, and intellectual passion. All participants in the peer-review and publication process must disclose all relationships that could be viewed as potential conflicts of interest. Disclosure of such relationships is also important in connection with editorials and review articles, because it can be more difficult to detect bias in these types of publications than in reports of original research. Editors may use information disclosed in conflict-of-interest and financial-interest statements as a basis for editorial decisions. When authors submit a manuscript, whether an article or a letter, they are responsible for disclosing all financial and personal relationships that might bias their work. To prevent ambiguity, authors must state explicitly whether potential conflicts do or do not exist. Authors should do so in the manuscript on a conflict-of-interest notification page, providing additional detail, if necessary, in a cover letter that accompanies the manuscript. Increasingly, individual studies receive funding from commercial firms, private foundations, and government. The conditions of this funding have the potential to bias and otherwise discredit the research. Scientists have an ethical obligation to submit creditable research results for publication. Moreover, as the persons directly responsible for their work, researchers should not enter into agreements that interfere with their access to the data and their ability to analyze them independently, and to prepare and publish manuscripts. Authors should describe the role of the study sponsor, if any, in study design; collection, analysis, and interpretation of data; writing the report; and the decision to submit the report for publication. If the supporting source had no such involvement, the authors should so state. Biases potentially introduced when sponsors are directly involved in research are analogous to methodological biases. Editors may request that authors of a study funded by an agency with a proprietary or financial interest in the outcome sign a statement, such as "I had full access to all of the data in this study and I take complete responsibility for the integrity of the data and the accuracy of the data analysis." Editors should be encouraged to review copies of the protocol and/or contracts associated with project-specific studies before accepting such studies for publication. Editors may choose not to consider an article if a sponsor has asserted control over the authors' right to publish. Reviewers must disclose to editors any conflicts of interest that could bias their opinions of the manuscript, and they should recuse themselves from reviewing specific manuscripts if the potential for bias exists. As in the case of authors, silence on the part of reviewers concerning potential conflicts may mean either that conflicts exist and the reviewer has failed to disclose them or conflicts do not exist. Reviewers must therefore also be asked to state explicitly whether conflicts do or do not exist. Reviewers must not use knowledge of the work, before its publication, to further their own interests. Editors who make final decisions about manuscripts must have no personal, professional, or financial involvement in any of the issues they might judge. Other members of the editorial staff, if they participate in editorial decisions, must provide editors with a current description of their financial interests (as they might relate to editorial judgments) and recuse themselves from any decisions in which a conflict of interest exists.


Informed Consent

PAGEPress journals strictly follows the ICMJE Protection of Research Participants policy detailed at http://www.icmje.org/recommendations/browse/roles-and-responsibilities/protection-of-research-participants.html Patients have a right to privacy that should not be violated without informed consent. When informed consent has been obtained, editors may request authors to provide a copy before making the editorial decision. Authors can find a template for the Informed Consent here. Manuscripts must be reviewed with due respect for authors' confidentiality. In submitting their manuscripts for review, authors entrust editors with the results of their scientific work and creative effort, on which their reputation and career may depend. Authors' rights may be violated by disclosure of the confidential details during review of their manuscript. Reviewers also have rights to confidentiality, which must be respected by the editor. Confidentiality may have to be breached if dishonesty or fraud is alleged but otherwise must be honored. Editors must not disclose information about manuscripts (including their receipt, content, status in the reviewing process, criticism by reviewers, or ultimate fate) to anyone other than the authors and reviewers. This includes requests to use the materials for legal proceedings.


Obligation to Register Clinical Trials (http://www.icmje.org/#clin_trials)
The ICMJE believes that it is important to foster a comprehensive, publicly available database of clinical trials. The ICMJE defines a clinical trial as any research project that prospectively assigns human subjects to intervention or concurrent comparison or control groups to study the cause-and-effect relationship between a medical intervention and a health outcome. Medical interventions include drugs, surgical procedures, devices, behavioral treatments, process-of-care changes, etc. Our journals require, as a condition of consideration for publication, registration in a public trials registry. The journal considers a trial for publication only if it has been registered before the enrollment of the first patient. The journal does not advocate one particular registry, but requires authors to register their trial in a registry that meets several criteria. The registry must be accessible to the public at no charge. It must be open to all prospective registrants and managed by a non-profit organization. There must be a mechanism to ensure the validity of the registration data, and the registry should be electronically searchable. An acceptable registry must include a minimum of data elements (http://www.icmje.org/#clin_trials). For example, ClinicalTrials.gov (http://www.clinicaltrials.gov), sponsored by the United States National Library of Medicine, meets these requirements.

 

Protection of Human Subjects and Animals in Research

When reporting experiments on human subjects, authors should indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2013. If doubt exists whether the research was conducted in accordance with the Helsinki Declaration, the authors must explain the rationale for their approach and demonstrate that the institutional review body explicitly approved the doubtful aspects of the study. An Informed Consent statement is always required from patients involved in any experiments. When reporting experiments on animals, authors should indicate whether the institutional and national guide for the care and use of laboratory animals was followed.  Further guidance on animal research ethics is available from the World Medical Association (2016 revision) and from the International Association of Veterinary Editors’ Consensus Author Guidelines on Animal Ethics and Welfare.